FFO
AURA icon

Fortitude Family Office’s Aura Biosciences AURA Stock Holding History

Fortitude Family Office’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50 Buy
+7
New +$50 ﹤0.01% 2206
2024
Q1 		– Sell
-227
Closed -$2.01K – 973
2023
Q4 		$2.01K Buy
+227
New +$1.92K ﹤0.01% 868

Other funds holding AURA

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Fortitude Family Office's AURA Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Aura Biosciences (AURA) in Q2 2026: 7 shares worth $50. The stake represents ﹤0.01% of the portfolio and ranks #2206 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in AURA as recently as Q4 2023.

Fortitude Family Office first reported a position in AURA in Q4 2023 and has held it in 2 quarters since. The position peaked at $2.01K in Q4 2023. 16 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Fortitude Family Office held 7 shares of Aura Biosciences worth $50 as of Q2 2026.
  • Aura Biosciences was a new Fortitude Family Office position in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2206 holding.
  • Fortitude Family Office first reported a position in Aura Biosciences in Q4 2023 and has held it in 2 quarters since.
  • Fortitude Family Office's Aura Biosciences position peaked at $2.01K in Q4 2023.
  • 16 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.